AG
EVH icon

Ascent Group’s Evolent Health EVH Stock Holding History

Ascent Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,765
Closed -$474K – 531
2024
Q3 		$474K Sell
16,765
-9,300
-36% -$240K 0.04% 382
2024
Q2 		$498K Buy
26,065
+5,735
+28% +$146K 0.04% 358
2024
Q1 		$667K Buy
20,330
+550
+3% +$17.6K 0.06% 315
2023
Q4 		$622K Buy
19,780
+4,180
+27% +$118K 0.06% 312
2023
Q3 		$432K Buy
15,600
+700
+5% +$19.5K 0.05% 337
2023
Q2 		$430K Sell
14,900
-450
-3% -$14.6K 0.05% 329
2023
Q1 		$498K Buy
15,350
+300
+2% +$9.49K 0.05% 320
2022
Q4 		$423K Sell
15,050
-200
-1% -$5.73K 0.05% 322
2022
Q3 		$485K Sell
15,250
-1,250
-8% -$44K 0.06% 293
2022
Q2 		$561K Buy
16,500
+550
+3% +$16K 0.07% 284
2022
Q1 		$515K Buy
15,950
+900
+6% +$23.6K 0.06% 296
2021
Q4 		$333K Buy
+15,050
New +$432K 0.04% 364

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ascent Group's EVH Position: Q4 2024 in Review

Ascent Group sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 16,765 shares — an estimated $474K sold.

Ascent Group first reported a position in EVH in Q4 2021 and held it in 12 quarters. The position peaked at $667K in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Ascent Group reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Ascent Group sold 16,765 Evolent Health shares in Q4 2024, an estimated $474K.
  • Ascent Group first reported a position in Evolent Health in Q4 2021 and held it in 12 quarters.
  • Ascent Group's Evolent Health position peaked at $667K in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Ascent Group's 13F filing for Q4 2024, filed 21 Feb 2025.